BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37758718)

  • 21. 90-kDa heat shock protein inhibition abrogates the topoisomerase I poison-induced G2/M checkpoint in p53-null tumor cells by depleting Chk1 and Wee1.
    Tse AN; Sheikh TN; Alan H; Chou TC; Schwartz GK
    Mol Pharmacol; 2009 Jan; 75(1):124-33. PubMed ID: 18820127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polycomb protein EZH2 regulates cancer cell fate decision in response to DNA damage.
    Wu Z; Lee ST; Qiao Y; Li Z; Lee PL; Lee YJ; Jiang X; Tan J; Aau M; Lim CZ; Yu Q
    Cell Death Differ; 2011 Nov; 18(11):1771-9. PubMed ID: 21546904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sterigmatocystin induces G1 arrest in primary human esophageal epithelial cells but induces G2 arrest in immortalized cells: key mechanistic differences in these two models.
    Wang J; Huang S; Xing L; Cui J; Tian Z; Shen H; Jiang X; Yan X; Wang J; Zhang X
    Arch Toxicol; 2015 Nov; 89(11):2015-25. PubMed ID: 25294323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expanding roles of cell cycle checkpoint inhibitors in radiation oncology.
    Hauge S; Eek Mariampillai A; Rødland GE; Bay LTE; Landsverk HB; Syljuåsen RG
    Int J Radiat Biol; 2023; 99(6):941-950. PubMed ID: 33877959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced sensitivity of celecoxib in human glioblastoma cells: Induction of DNA damage leading to p53-dependent G1 cell cycle arrest and autophagy.
    Kang KB; Zhu C; Yong SK; Gao Q; Wong MC
    Mol Cancer; 2009 Aug; 8():66. PubMed ID: 19706164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitors of cell cycle checkpoint target Wee1 kinase - a patent review (2003-2022).
    Yan J; Zhuang L; Wang Y; Jiang Y; Tu Z; Dong C; Chen Y; Zhu Y
    Expert Opin Ther Pat; 2022 Dec; 32(12):1217-1244. PubMed ID: 36620912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic inhibition of the atypical kinase Wee1 selectively drives apoptosis of p53 inactive tumor cells.
    Pappano WN; Zhang Q; Tucker LA; Tse C; Wang J
    BMC Cancer; 2014 Jun; 14():430. PubMed ID: 24927813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization and preclinical development of LY2603618: a selective and potent Chk1 inhibitor.
    King C; Diaz H; Barnard D; Barda D; Clawson D; Blosser W; Cox K; Guo S; Marshall M
    Invest New Drugs; 2014 Apr; 32(2):213-26. PubMed ID: 24114124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. WEE1 kinase targeting combined with DNA-damaging cancer therapy catalyzes mitotic catastrophe.
    De Witt Hamer PC; Mir SE; Noske D; Van Noorden CJ; Würdinger T
    Clin Cancer Res; 2011 Jul; 17(13):4200-7. PubMed ID: 21562035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell cycle involvement in cancer therapy; WEE1 kinase, a potential target as therapeutic strategy.
    Vakili-Samiani S; Khanghah OJ; Gholipour E; Najafi F; Zeinalzadeh E; Samadi P; Sarvarian P; Pourvahdani S; Kelaye SK; Hamblin MR; Feizi AAH
    Mutat Res; 2022; 824():111776. PubMed ID: 35247630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological inactivation of CHK1 and WEE1 induces mitotic catastrophe in nasopharyngeal carcinoma cells.
    Mak JP; Man WY; Chow JP; Ma HT; Poon RY
    Oncotarget; 2015 Aug; 6(25):21074-84. PubMed ID: 26025928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preclinical effects of honokiol on treating glioblastoma multiforme via G1 phase arrest and cell apoptosis.
    Lin CJ; Chang YA; Lin YL; Liu SH; Chang CK; Chen RM
    Phytomedicine; 2016 May; 23(5):517-27. PubMed ID: 27064011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Temozolomide Induces Senescence and Repression of DNA Repair Pathways in Glioblastoma Cells via Activation of ATR-CHK1, p21, and NF-κB.
    Aasland D; Götzinger L; Hauck L; Berte N; Meyer J; Effenberger M; Schneider S; Reuber EE; Roos WP; Tomicic MT; Kaina B; Christmann M
    Cancer Res; 2019 Jan; 79(1):99-113. PubMed ID: 30361254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. WEE1 kinase inhibitor MK-1775 sensitizes oral tongue squamous cell carcinoma cells to radiation irrespective of TP53 status.
    Al-Jamaei AH; de Visscher JGAM; Subramanyam VR; Forouzanfar T; Sminia P; Doulabi BZ; Helder MN
    Oral Dis; 2023 Oct; 29(7):2640-2649. PubMed ID: 35672254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histone deacetylase inhibitors promote glioma cell death by G2 checkpoint abrogation leading to mitotic catastrophe.
    Cornago M; Garcia-Alberich C; Blasco-Angulo N; Vall-Llaura N; Nager M; Herreros J; Comella JX; Sanchis D; Llovera M
    Cell Death Dis; 2014 Oct; 5(10):e1435. PubMed ID: 25275596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulation of Myt1 Promotes Acquired Resistance of Cancer Cells to Wee1 Inhibition.
    Lewis CW; Bukhari AB; Xiao EJ; Choi WS; Smith JD; Homola E; Mackey JR; Campbell SD; Gamper AM; Chan GK
    Cancer Res; 2019 Dec; 79(23):5971-5985. PubMed ID: 31594837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 3-O-acetyl-11-keto-β-boswellic acid exerts anti-tumor effects in glioblastoma by arresting cell cycle at G2/M phase.
    Li W; Liu J; Fu W; Zheng X; Ren L; Liu S; Wang J; Ji T; Du G
    J Exp Clin Cancer Res; 2018 Jul; 37(1):132. PubMed ID: 29970196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA-dependent protein kinase: effect on DSB repair, G2/M checkpoint and mode of cell death in NSCLC cell lines.
    Sak A; Groneberg M; Stuschke M
    Int J Radiat Biol; 2019 Sep; 95(9):1205-1219. PubMed ID: 31287365
    [No Abstract]   [Full Text] [Related]  

  • 39. Antitumor effect of WEE1 blockade as monotherapy or in combination with cisplatin in urothelial cancer.
    Murakami K; Kita Y; Sakatani T; Hamada A; Mizuno K; Nakamura K; Takada H; Matsumoto K; Sano T; Goto T; Akamatsu S; Saito R; Tsuruyama T; Ogawa O; Kobayashi T
    Cancer Sci; 2021 Sep; 112(9):3669-3681. PubMed ID: 34212455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of mitotic cell death by overriding G2/M checkpoint in endometrial cancer cells with non-functional p53.
    Meng X; Laidler LL; Kosmacek EA; Yang S; Xiong Z; Zhu D; Wang X; Dai D; Zhang Y; Wang X; Brachova P; Albitar L; Liu D; Ianzini F; Mackey MA; Leslie KK
    Gynecol Oncol; 2013 Mar; 128(3):461-9. PubMed ID: 23146687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.